Auxly Cannabis Group Stock Today
| XLY Stock | CAD 0.04 0 7.14% |
Performance1 of 100
| Odds Of DistressOver 84
|
Auxly Cannabis is selling at 0.0375 as of the 28th of November 2024; that is 7.14 percent increase since the beginning of the trading day. The stock's open price was 0.035. Auxly Cannabis has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Auxly Cannabis Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada. AUXLY CANNABIS operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. The company has 1.25 B outstanding shares of which 348.01 K shares are at this time shorted by private and institutional investors with about 0.88 days to cover all short positions. More on Auxly Cannabis Group
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Auxly Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Auxly Cannabis' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Auxly Cannabis or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
Auxly Cannabis' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Auxly Cannabis' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAuxly Cannabis can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Auxly Cannabis' financial leverage. It provides some insight into what part of Auxly Cannabis' total assets is financed by creditors.
| |||||
Auxly Cannabis Group (XLY) is traded on Toronto Exchange in Canada and employs 369 people. Auxly Cannabis is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 44.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Auxly Cannabis's market, we take the total number of its shares issued and multiply it by Auxly Cannabis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Auxly Cannabis Group operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.25 B outstanding shares of which 348.01 K shares are at this time shorted by private and institutional investors with about 0.88 days to cover all short positions.
Auxly Cannabis Group has accumulated about 14.64 M in cash with 8.21 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Auxly Cannabis Probability Of Bankruptcy
Ownership AllocationAuxly Cannabis holds a total of 1.25 Billion outstanding shares. Auxly Cannabis Group retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Auxly Ownership Details
Auxly Cannabis Group Risk Profiles
Although Auxly Cannabis' alpha and beta are two of the key measurements used to evaluate Auxly Cannabis' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 7.06 | |||
| Semi Deviation | 7.7 | |||
| Standard Deviation | 9.76 | |||
| Variance | 95.25 |
Auxly Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Auxly Cannabis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Auxly Cannabis Corporate Management
Elected by the shareholders, the Auxly Cannabis' board of directors comprises two types of representatives: Auxly Cannabis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Auxly. The board's role is to monitor Auxly Cannabis' management team and ensure that shareholders' interests are well served. Auxly Cannabis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Auxly Cannabis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ian Rapsey | Chief Officer | Profile | |
| Ron Fichter | General Secretary | Profile | |
| Hugo Alves | CEO Director | Profile | |
| Vladimir Klacar | Senior Planning | Profile | |
| Alan Cooke | VP Operations | Profile | |
| Brian Schmitt | Chief Officer | Profile | |
| Kevin Furet | Chief Officer | Profile |
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.